Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Gastrointestinal Endoscopy|February 4, 2012
Vital-dye enhanced fluorescence imaging of GI mucosa: metaplasia, neoplasia, inflammationNadhi Thekkek, Timothy Muldoon, Alexandros D Polydorides, et al.
Advances in Radiation Oncology|November 9, 2017
Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort studyAnhui Shi, Zhongxing Liao, Pamela K Allen, et al.
British Journal of Cancer|June 9, 2016
Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancerMichael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, et al.
Cancer|April 2, 2011
Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapyAkihiro Suzuki, Lianchun Xiao, Yuki Hayashi, et al.
Oncology|June 14, 2014
Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancerHironori Shiozaki, Kazuki Sudo, Lianchun Xiao, et al.
Cancer|October 21, 2010
Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experiencePanteleimon Kountourakis, Arlene M Correa, Wayne L Hofstetter, et al.
Annals of Diagnostic Pathology|September 11, 2014
Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancerJane H Zhou, Daniel Rosen, Andreas Andreou, et al.
Annals of Surgery|May 24, 2014
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter studyJunichi Shindoh, Xabier de Aretxabala, Thomas A Aloia, et al.
Cancer|July 23, 2013
Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastasesAntoine Brouquet, Giuseppe Zimmitti, Scott Kopetz, et al.
Cancer|February 10, 2010
Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junctionJaffer A Ajani, Arlene M Correa, Garrett L Walsh, et al.
Pageof 12